| Title | Author(s) | Year | View Count |
 | Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker | Chen, L; Ho, DWY; Lee, NPY; Sun, S; Lam, B; Wong, KF; Yi, X; Lau, GK; Ng, EWY; Poon, TCW; Lai, PBS; Cai, Z; Peng, J; Leng, X; Poon, RTP; Luk, JM | 2010 | 269 |
 | Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma | Lee, NP; Chen, L; Lin, MC; Tsang, FH; Yeung, C; Poon, RT; Peng, J; Leng, X; Beretta, L; Sun, S; Day, PJ; Luk, JM | 2009 | 166 |
| SELDI protein chip technology for the detection of serum biomarkers for liver disease | Chen, L; Fatima, S; Peng, J; Leng, X | 2009 | 105 |
| Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence | Yi, X; Luk, JM; Lee, NP; Peng, J; Leng, X; Guan, XY; Lau, GK; Beretta, L; Fan, ST | 2008 | 94 |
| Artificial neural networks and decision tree model analysis of liver cancer proteomes | Luk, JM; Lam, BY; Lee, NPY; Ho, DW; Sham, PC; Chen, L; Peng, J; Leng, X; Day, PJ; Fan, ST | 2007 | 129 |
 | Applicability of proteomic biomarkers set to distinguish hepatocellular carcinoma from non-tumor and healthy liver tissues | Luk, JMC; Lam, BKY; Yi, X; Peng, J; Leng, X; Fan, ST | 2005 | 84 |
| Applicability of proteomic biomarkers set to distinguish hepatocellular carcinoma from non-tumor and healthy liver tissues | Luk, JMC; Lam, BYH; Yi, X; Peng, J; Leng, X; Fan, ST | 2005 | 63 |
|
